The Mitochondrial Biogenesis and Dynamics in Health and Disease Conference
19-24 May, 2019
PalmSpring, California, USA
ENYO Pharma will be present at The Mitochondrial Biogenesis and Dynamics in Health and Disease Conference meeting from the 19th to the 24th of May at Palm Spring and presented a poster on the topic: “Chemical targeting of NEET/CISDs proteins reveals the central role of mitochondrial morphodynamics regulation in viral infection”.
MIMESIS Newsletter #4: A novel systems biology approach to develop preclinical assets
MIMESIS NEWSLETTER #4, December 2018
After two years, ENYO Pharma’s EU funded MIMESIS project was a real success and has delivered several promising new drug development starting points most significantly for RSV and ICD.
MIMESIS is a research and innovation project coordinated by ENYO Pharma and funded under the highly selective H2020 – SMEInstrument – Phase 2 call that aims at: “Dedicated support to biotechnology SMEs closing the gap from lab to market”.
J.P. Morgan 37th Annual Healthcare Conference
7 – 10 January, 2019
San Francisco, USA
“ENYO Pharma team will be at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.” (jpmorgan.com)
BioFIT 2018
4 – 5 December, 2018
Lille, France
ENYO Pharma’s CEO Jacky Vonderscher has been invited to speak in the conference programme of BioFIT 2018 in Lille, France, on December 4th and 5th. He had the opportunity to share his experience and knowledge during the following session – agnostic or pure players in the biotech sector: who is becoming prominent in the early-stage financing rounds? He was also able to give ENYO’s experience feedback following the first fundraising in 2016.
Latest Press Release 